2-aminoindan has been researched along with rasagiline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amit, T; Bar-Am, O; Weinreb, O; Youdim, MB | 1 |
| Dimpfel, W; Hoffmann, JA | 1 |
| Kakish, J; Lee, JS; Tavassoly, O | 1 |
1 review(s) available for 2-aminoindan and rasagiline
| Article | Year |
|---|---|
The neuroprotective mechanism of 1-(R)-aminoindan, the major metabolite of the anti-parkinsonian drug rasagiline.
Topics: Animals; Cytochrome P-450 Enzyme System; Humans; Indans; Models, Chemical; Neuroprotective Agents; Parkinson Disease; Proto-Oncogene Proteins c-bcl-6 | 2010 |
2 other study(ies) available for 2-aminoindan and rasagiline
| Article | Year |
|---|---|
Effects of rasagiline, its metabolite aminoindan and selegiline on glutamate receptor mediated signalling in the rat hippocampus slice in vitro.
Topics: Action Potentials; Animals; Dose-Response Relationship, Drug; Electric Stimulation; Hippocampus; In Vitro Techniques; Indans; Male; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Glutamate; Selegiline; Signal Transduction | 2011 |
Rasagiline, a suicide inhibitor of monoamine oxidases, binds reversibly to α-synuclein.
Topics: alpha-Synuclein; Calorimetry; Indans; Methamphetamine; Monoamine Oxidase Inhibitors; Nanopores; Neuroprotective Agents; Protein Binding; Selegiline | 2015 |